Assignee
SERAGON PHARMACEUTICALS INC
US·5 granted patents·2 pending applications·90 citations·filing 2012–2021
Top patents by PatentIndex Score
7 records- 0196US9078871B2Estrogen receptor modulators and uses thereofSERAGON PHARMACEUTICALS INC·Filed 2013·Granted Jul 14, 2015·50 cites·22 claims
- 0291US9193714B2Fluorinated estrogen receptor modulators and uses thereofSERAGON PHARMACEUTICALS INC·Filed 2012·Granted Nov 24, 2015·18 cites·14 claims
- 0388US9187460B2Estrogen receptor modulators and uses thereofSERAGON PHARMACEUTICALS INC·Filed 2012·Granted Nov 17, 2015·11 cites·17 claims
- 0483US9586952B2Polycyclic estrogen receptor modulators and uses thereofSERAGON PHARMACEUTICALS INC·Filed 2014·Granted Mar 7, 2017·7 cites·37 claims
- 0578US9499538B2Estrogen receptor modulators and uses thereofSERAGON PHARMACEUTICALS INC·Filed 2013·Granted Nov 22, 2016·4 cites·13 claims
- 0656US2022157469A1Methods of predicting age, and identifying and treating conditions associated with aging using spectral clustering and discrete cosine transformSERAGON PHARMACEUTICALS INC·Filed 2021·Application pending·0 cites
- 0750US2022136037A1Methods of predicting age, and identifying and treating conditions associated with agingSERAGON PHARMACEUTICALS INC·Filed 2021·Application pending·0 cites
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →